Difference between revisions of "Part:BBa K4229072"
 
(2 intermediate revisions by one other user not shown)
Line 3: Line 3:
 
<partinfo>BBa_K4229072 short</partinfo>
 
<partinfo>BBa_K4229072 short</partinfo>
  
 +
BMC-T1-T35TAG
 
Short Description:
 
Short Description:
−
 
+
The T35TAG variant of BMC-T1(BBa_K4229037) was created using site-directed mutagenesis, aiming to insert a non-canonical amino acid at position 8 of the peptide sequence by amber stop codon suppression. The BMC-T1_T35TAG can only be completely synthesized upon successful amber stop codon suppression. Hence, BMC-T1_T35TAG can be used to create a ncAA modified shell protein for the assembly of a synthetic carboxysome.
−
The T35X variant of BMC-T1 was created using site-directed mutagenesis, aiming to insert a non-canonical amino acid at position 8 of the peptide sequence by amber stop codon. The BMC-T1_T35X can only be completely synthesized upon successful amber stop codon suppression. Hence, BMC-T1_T35X can be used to create a ncAA modified shell protein for the assembly of a synthetic carboxysome.
+
  
  
 
Usage:
 
Usage:
−
 
+
Besides the well-known 20 canonical amino acids, a variety of non-canonical amino acids can be used to modify proteins. One way of incorporating non-canonical amino acids is via the amber stop codon suppression technology. BMC-T1_T35TAG is a mutated version of the BMC-T1 protein, necessary to form the synthetic BMC of the myxobacterium Haliangium ochraceum. Without successful incorporation, a non-functional version of BMC-T1 will be translated, and the synthetic carboxysome cannot form. However, after successful incorporation of the non-canonical amino acid, translation will go on as normal and the synthetic carboxysome can form.
−
Besides the well-known 20 canonical amino acids, there is a variety of non-canonical amino acids which can be used to further modify proteins. One way of incorporating non-canonical amino acids is via the amber stop codon suppression technology. This part BMC-T1_T35X, is a model protein to test non-canonical amino acid incorporation. Without successful incorporation, a non-functional version of BMC-T1 will be translated, and the synthetic carboxysome cannot form. However, after successful incorporation of the non-canonical amino acid, translation will go on as normal and the synthetic carboxysome can form.
+
  
  
 
Characterization:  
 
Characterization:  
 +
The incorporation of non-canonical amino acids into BMC-T1_T35TAG was characterized using SDS-PAGE, Western blot, and antibody decoration.  As an orthogonal translation system, an additional aminoacyl-tRNA synthetase and its corresponding tRNA are required, which in this case correspond to the pAzF tRNA synthetase (pAzFRS), which incorporates 4-azido-l-phenylalanine. 
  
−
The incorporation of non-canonical amino acids into BMC-T1_T35X was characterized using SDS-PAGE, Western blot, and antibody decoration.  As an orthogonal translation system, an additional aminoacyl-tRNA synthetase and its corresponding tRNA are used, which in this case correspond to the pBpf synthetase, which incorporates 4-Benzoyl-l-phenylalanine. 
+
[[File:T1MutWestern.jpg|800px|thumb|left|Figure text: SDS-PAGE with whole cell lysis confirming the incorporation of pAzF at position 8, 35, 78 and 96 of the BMC-T1 protein. The cells grew until OD 0.4, following the addition of arabinose and a growth period of 2 hours. After 2 hours, the cells were treated with IPTG and grew 24 hours before harvesting by centrifugation. The BlueClassic Prestained Protein Marker, 10-180 kDa from Jena Bioscience was used for orientation. To purify the protein, the His-Spin Protein Miniprep from Zymo Research was used. ]]
−
 
+
−
[[File:T1MutWestern.jpg|800px|thumb|left|Figure text: SDS-PAGE with whole cell lysis confirming the incorporation of pAzF at position 8, 35, 78 and 96 of the BMC-T1 protein. The cells grew until OD 0.4, following the addition of arabinose and a growth period of 2 h. After the 2 h the cells were treated with IPTG and grew 24 hours before harvesting by centrifugation. The BlueClassic Prestained Protein Marker, 10-180 kDa from Jena Bioscience was used as ladder. To purify the protein, the His-Spin Protein Miniprep from Zymo Research was used. ]]
+
−
 
+
−
 
+
  
  
Line 64: Line 61:
  
  
 +
The plasmid containing this protein was kindly sent to us by the Kerfeld group.
  
 +
H. Kirst and C. A. Kerfeld, “Bacterial microcompartments: Catalysis-enhancing metabolic modules for next-generation metabolic and biomedical engineering,” BMC Biol., vol. 17, no. 1, pp. 1–11, 2019, DOI: 10.1186/s12915-019-0691-z.
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here

Latest revision as of 17:35, 11 October 2022


BMC-T1_T35TAG

BMC-T1-T35TAG Short Description: The T35TAG variant of BMC-T1(BBa_K4229037) was created using site-directed mutagenesis, aiming to insert a non-canonical amino acid at position 8 of the peptide sequence by amber stop codon suppression. The BMC-T1_T35TAG can only be completely synthesized upon successful amber stop codon suppression. Hence, BMC-T1_T35TAG can be used to create a ncAA modified shell protein for the assembly of a synthetic carboxysome.


Usage: Besides the well-known 20 canonical amino acids, a variety of non-canonical amino acids can be used to modify proteins. One way of incorporating non-canonical amino acids is via the amber stop codon suppression technology. BMC-T1_T35TAG is a mutated version of the BMC-T1 protein, necessary to form the synthetic BMC of the myxobacterium Haliangium ochraceum. Without successful incorporation, a non-functional version of BMC-T1 will be translated, and the synthetic carboxysome cannot form. However, after successful incorporation of the non-canonical amino acid, translation will go on as normal and the synthetic carboxysome can form.


Characterization: The incorporation of non-canonical amino acids into BMC-T1_T35TAG was characterized using SDS-PAGE, Western blot, and antibody decoration. As an orthogonal translation system, an additional aminoacyl-tRNA synthetase and its corresponding tRNA are required, which in this case correspond to the pAzF tRNA synthetase (pAzFRS), which incorporates 4-azido-l-phenylalanine.

Figure text: SDS-PAGE with whole cell lysis confirming the incorporation of pAzF at position 8, 35, 78 and 96 of the BMC-T1 protein. The cells grew until OD 0.4, following the addition of arabinose and a growth period of 2 hours. After 2 hours, the cells were treated with IPTG and grew 24 hours before harvesting by centrifugation. The BlueClassic Prestained Protein Marker, 10-180 kDa from Jena Bioscience was used for orientation. To purify the protein, the His-Spin Protein Miniprep from Zymo Research was used.























The plasmid containing this protein was kindly sent to us by the Kerfeld group.

H. Kirst and C. A. Kerfeld, “Bacterial microcompartments: Catalysis-enhancing metabolic modules for next-generation metabolic and biomedical engineering,” BMC Biol., vol. 17, no. 1, pp. 1–11, 2019, DOI: 10.1186/s12915-019-0691-z.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NotI site found at 706
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 36
    Illegal AgeI site found at 510
    Illegal AgeI site found at 618
  • 1000
    COMPATIBLE WITH RFC[1000]